‘Global HIV drug firms fleecing developing nations’

A LEADING global HIV and Aids advocacy organisation, the Aids Healthcare Foundation has accused global HIV/Aids drug producers and
suppliers of fleecing developing nations.

Speaking at a Press conference in Harare on Wednesday, African Bureau for Aids Healthcare Foundation director for advocacy, policy and marketing, Oluwakemi Gbadamosi said Western pharmaceuticals continue to exploit developing countries by overpricing medication.

“Gilead has priced several of its HIV and hepatitis C drugs out of reach of many people, and refused to register some drugs in developing countries. 

This story is for NewsDay subscribers.